NICE has been notified about this procedure and it is part of its work programme. The Interventional Procedures Advisory Committee (IPAC) will consider this procedure and NICE will issue an interventional procedures consultation document about its safety and efficacy for 4 weeks’ public consultation. IPAC will then review the consultation document in the light of comments received and produce a final interventional procedures document, which will be considered by NICE before guidance is issued to the NHS in England, Wales, Scotland and Northern Ireland
Status Awaiting development
Technology type Procedure
Decision Selected
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
Process IP
ID number 1293
Description Transcutaneous electrical stimulation of the supraorbital nerve uses small electrical currents to stimulate the supraorbital nerves (branches of the ophthalmic nerve, the first division of the trigeminal nerve) through the skin overlying the nerves. It is also called eTNS. The aim is to relieve headache and, when used regularly, to reduce the severity and the frequency of migraine attacks. People with migraine administer the therapy themselves using a small battery-operated device. For example, 1 device consists of a headband with a central button connected to a self-adhesive electrode patch. This is applied to the forehead above the eyebrows. When the device is activated, small electrical impulses stimulate the supraorbital nerves (branches of the ophthalmic nerve, the first division of the trigeminal nerve). The intensity of the electrical pulses increases periodically and can be self-adjusted. Stimulation is applied daily for about 1 to 2 hours during an acute migraine attack, and for 20 minutes for prevention between attacks.

Provisional Schedule

Expected publication 26 October 2022

Email enquiries


Key events during the development of the guidance:

Date Update
11 August 2022 Committee meeting: 2
31 May 2022 - 30 June 2022 Interventional procedure consultation
04 May 2022 Awaiting development. Status change linked to Topic Selection Decision being set to Selected
14 April 2022 Committee meeting: 1
11 June 2020 Topic selection. IPAC 0

For further information on how we develop interventional procedures guidance, please see our IP manual